Recently, the innovative product "Implantable Cardiac Pacing Lead" of MicroPort Sorin CRM (Shanghai) Co., Ltd. is approved for marketing by China NMPA.

This product consists of leads and accessories, which, when combined with a compatible pacemaker, forms an implantable cardiac pacing system. It is primarily used for pacing and sensing in the atrium and ventricle.

This product can effectively reduce myocardial tissue temperature rise during MRI scans, better meeting the clinical needs of arrhythmia patients for 1.5T magnetic resonance imaging.

The NMPA will strengthen the post-marketing surveillance of the product to protect the safety of medical devices used by patients.